BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T090000
DTEND;TZID=America/New_York:20240221T100000
DTSTAMP:20260410T095536
CREATED:20240207T213516Z
LAST-MODIFIED:20241024T183019Z
UID:10000727-1708506000-1708509600@staging.digitalinsights.supremeclients.com
SUMMARY:How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development
DESCRIPTION:The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity\, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. \nIn this talk\, our experts discuss how biopharmaceutical companies can leverage key genomic\, biomedical\, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases\, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN\, and how to use these resources to better predict cancer-driving effects of mutations\, identify available drugs that target specific variants\, and accelerate indication expansion and repurposing of existing cancer therapies. \nLearning objectives: \n1. Examine use-cases of how to leverage expert-curated databases across multiple phases of cancer drug development. \n2. Discover key applications of these databases\, including determining the function\, frequency\, and actionability of specific mutations. \n3. Discuss potential pitfalls and clinical consequences\, and how to avoid them early with data-driven drug target and biomarker qualification.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-biopharmaceutical-companies-can-leverage-expert-curated-knowledge-from-wellcome-sanger-institute-and-qiagen-to-accelerate-cancer-drug-discovery-and-development/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1366_2_QDI_QCI_HSMDvsCOSMIC_Biopharmam.jpg
END:VEVENT
END:VCALENDAR